MagneGas Corporation (Nasdaq:MNGA) announced it signed an expanded joint venture agreement with technology partner Future Energy Pty Ltd of Australia. Under the terms of the agreement, both parties will own 50% of a new Company formed for the purpose of developing, licensing and commercializing new intellectual property for co-combustion of MagneGas fuels with hydrocarbon fuels to reduce emissions and increase energy. MagneGas Corporation (NASDAQ:MNGA) shares after opening at $1.58 moved to $1.82 on last trade day and at the end of the day closed at $1.62. Company price to sales ratio in past twelve months was calculated as 98.63 and price to cash ratio as 82.19. MagneGas Corporation (NASDAQ:MNGA) showed a negative weekly performance of -24.65%.
OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, reported financial results and reviewed corporate events for the year and quarter ended December 31, 2013. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) shares advanced 15.87% in last trading session and ended the day on $33.65. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) return on equity ratio is recorded as 145.10% and its return on assets is -22.50%.
Cleantech Solutions International (NASDAQ:CLNT) climbed 21.92% to $6.62 after the company reported Q4 results. Cleantech Solutions reported its Q4 earnings of $0.60 per share on revenue of $22.80 million. Cleantech Solutions International Inc (NASDAQ:CLNT) shares moved up 18.05% in last trading session and was closed at $6.41 while trading in range of $6.32 -$7.20 – Cleantech Solutions International Inc (NASDAQ:CLNT) year to date (YTD) performance is 79.55%.
TheStreet Ratings team rates Vimicro International Corporation (ADR) (NASDAQ:VIMC) as a “sell” with a ratings score of D+. Vimicro International Corporation (ADR) (NASDAQ:VIMC) weekly performance is 35.42%. On last trading day company shares ended up $4.97. Vimicro International Corporation (ADR) (NASDAQ:VIMC) distance from 50-day simple moving average (SMA50) is 48.90%. Analysts mean target price for the company is $4.50.